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A B S T R A C T
Background: Thickening of the pericoronary adipose tissue (PCAT) is a proven risk factor for coronary
artery disease, but it is poorly understood whether PCAT stores pro-atherogenic substances with
oxidized low-density lipoprotein (oxLDL) and low-density lipoprotein (LDL), and an anti-atherogenic
substance with high-density lipoprotein (HDL) and supply them to the coronary intima.
Methods: Using immunohistochemical techniques, the localization of oxLDL, LDL and HDL in PCAT and
its adjacent coronary segments was examined in 30 epicardial coronary arteries excised from 11 human
autopsy cases.
Results: PCAT stored oxLDL and HDL in all, but LDL rarely, in 77 specimens examined, irrespective of the
presence or absence of coronary plaques and underlying disease. The percentage (%) incidence of oxLDL,
HDL and LDL deposits in intima was, respectively, 28, 10, 35 in 29 normal segments, 80 (p < 0.05 vs.
normal segments), 12, 75 in 19 white plaques (growth stage), 57, 36, 90 in 15 yellow plaques without
necrotic core (NC; mature stage), and 40, 21, 100 (p < 0.05 vs. normal segments) in 14 yellow plaques
with NC (end-stage of maturation) as classiﬁed by angioscopy and histology.
In coronary intima, oxLDL deposited in either a dotted or diffuse pattern whereas HDL and LDL
showed diffuse patterns. Dotted oxLDL deposits were contained in CD68(+)-macrophages traversing the
border of PCAT and adventitia, external and internal elastic laminae. Diffuse oxLDL and HDL deposits
colocalized with intimal vasa vasorum.
Conclusions: The results suggested that, as a hitherto unrecognized supplying route, the human PCAT
stores oxLDL and HDL and oxLDL is supplied to coronary intima either by CD68(+)-macrophages or vasa
vasorum and HDL by vasa vasorum, and that deposition of oxLDL and HDL in the intima increased with
plaque growth but the former decreased while the latter increased further with plaque maturation.
Molecular therapy targeting PCAT before plaque maturation could be effective in preventing
atherosclerosis.
 2016 The Author(s). Published by Elsevier Ltd on behalf of Japanese College of Cardiology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Pericoronary adipose tissue (PCAT) lies on the epicardial
coronary artery and is part of the epicardial adipose tissue. PCAT
is considered to release, as in the case of other perivascular adipose
tissues, a wide range of cytokines that modulate vascular smooth
muscle cell contraction, proliferation and migration. In addition, it of Cardiology. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Procedure of the present study.
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leukin-8 and monocyte chemoattractant protein-1, which con-
tribute to adventitial inﬂammation and atherosclerosis
development [1–9]. Oxidized low-density lipoprotein (oxLDL),
derived from LDL is the core substance that induces atherosclerosis
and is a clinically proven risk factor for coronary events [10–13];
their counterpart, high-density lipoprotein (HDL) decreases the risk
of coronary heart disease by facilitating cholesterol uptake from
cholesterol-loaded macrophage-foam cells in plaques for transport
back to the liver [14–16]. However, it is poorly understood whether
these lipoproteins are stored in human PCAT, and are supplied to the
adjacent coronary artery to induce or suppress atherosclerosis.
We examined by immunohistochemical techniques whether or
not the human PCAT acts as a storage and supply site of these
substances to the adjacent coronary intima, which is the site of
atherosclerosis.
Materials and methods
Angioscopic and immunohistochemical studies of excised human PCAT
and adjacent coronary artery
Ethics
This ex vivo study was carried out after approval of the ethical
committees of the Japan Foundation for Cardiovascular Research,
Funabashi-Futawa Hospital and Toho University, and after
obtaining written informed consent from the families concerned
on the use of excised coronary artery and surrounding adipose
tissue for angioscopic and histological studies to clarify the
mechanisms of atherosclerosis.
Subjects
The 30 proximal to middle segments of coronary arteries
(11 left anterior descending arteries, 9 left circumﬂex arteries,
10 right coronary arteries) and surrounding adipose tissue were
carefully excised from 11 successive patients who had died and
were autopsied from April 1, 2010 and May 31, 2015 at Funabashi-
Futawa Hospital or Toho University Medical Center Sakura
Hospital [61.2  3.4 years (mean  SD); 3 females, 8 males; death
from acute myocardial infarction (3), diabetic nephropathy (3),
cerebral infarction (1), subarachnoid hemorrhage (1), visceral cancer
(2), sudden death (1)].
Classiﬁcation of coronary plaques and normal segments by
conventional angioscopy
In the present study, a conventional coronary angioscopy
system (details described elsewhere [17]) was used to classify
coronary plaques and normal segments.
Plaques and normal segments. By conventional coronary angio-
scopy, plaque was deﬁned as a nonmobile, protruding or lining
mass clearly demarcated from the adjacent normal wall and with a
shape, location and color that did not alter after saline ﬂushing. A
normal segment was deﬁned as a milky-white and smooth-
surfaced portion without any protrusions [18].
Plaque color assessment. Because color deﬁnition differs observer
to observer, inﬂuenced by their experience and visual sense, we
developed a more objective method for color deﬁnition.
Color is a spectrum of visible light wavelengths. A given visible
color band changes successively to the next, and there are no
deﬁnite border between two color bands. This is the reason why
color deﬁnition differs observer to observer, inﬂuenced by their
experience and visual sense. Therefore, we developed a more
objective method for color deﬁnition. Namely, plaque images
obtained by conventional angioscopy were classiﬁed as white oryellow by an AquaCosmos image analyzer (C7746, Hamamatsu
Photonics, Hamamatsu).
Namely, based on the relationship between color spectrum
generated through a prism by a Xenon lamp and its light wavelength,
the light wavelength of ‘‘yellow’’ was deﬁned as 575 2 595-nm. The
color band of this area was imaged through an angioscope and it was
separated by the image analyzer into three primary colors, namely
red, green and blue. The intensity ratio of red: green: blue of yellow
color was 1.0:1.38–1.46:0.47–0.60. Therefore, plaque color was
deﬁned as ‘‘yellow’’ when its intensity ratio was within this range.
Similarly, white light which was generated by the Xenon lamp was
separated into three primary colors. The intensity ratio of white
color was 1.0:0.9–1.1:0.9–1.1. Therefore, plaque color was deﬁned
as ‘‘white’’ when the intensity ratio was within this range [19].
Observation of excised coronary arteries by conventional angioscopy
A Y-connector was introduced into the proximal portion of the
respective coronary artery for perfusion with saline solution at a
rate of 20 mL/min and then the angioscope was introduced
through the connector into the artery to evaluate it for plaques. A
total of 29 normal segments, 19 white plaques and 29 yellow
plaques, which matched the aforementioned criteria, were
conﬁrmed by conventional angioscopy in 30 coronary arteries.
Externally, the location of each observed plaque or normal
segment could be identiﬁed because the light irradiated by the
angioscope tip was visible through the arterial wall (Fig. 1).
Selection of plaques and normal segments. The 4–5-mm long section
of artery in which the observed plaque was located and its
surrounding PCAT were isolated by transecting its proximal and
distal ends at the shorter axes. Normal segments were similarly
isolated. In total, 29 normal segments, 19 white plaques, 29 yellow
plaques, and 29 normal segments, surrounded by PCAT, were
classiﬁed using images recorded on digital video disks by two
independent observers who did not participate in conventional
angioscopy. They randomly selected the normal segments and
plaques for further examination, and embedded them in O.C.T.
Compound (Sakura Fintek USA Inc., Torrance, CA, USA) before
being stored at 20 8C.
Immunohistochemistry of OxLDL, CD68(+)-macrophages and CD31
(endothelial cells of vasa vasorum)
Deﬁnition of PCAT. Epicardial adipose tissue located within 3 mm
(diameter of the proximal to middle segments of a coronary artery)
of the external elastic lamina of an epicardial coronary artery was
arbitrarily deﬁned as PCAT because it was more likely to directly
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located remotely, based on the observation of microvessels
penetrating from the PCAT to the epicardial coronary arterial wall
within a few millimeters of the coronary arterial wall [20].
Immunohistochemical staining. All plaques and normal segments
with their surrounding PCAT, which had been stored at 20 8C, were
cut into successive 20 mm sections on a cryostat (Tissue Tec 3D,
Sakura Finetec Japan, Tokyo). Such relatively thick and frozen
sections were used to prevent any substances leaking from the fresh
PCAT. Next, the sections were ﬁxed with 4% paraformaldehyde
solution for 7 min at 4 8C, incubated with a mixture of 1% hydrogen
peroxide in methanol for 30 min. Successive sections were stained
immunohistochemically in the order of oxLDL, LDL, HDL, CD68 for
macrophages and CD31 for endothelial cells of vasa vasorum
(arising from the mother vessel and/or penetrating microvessels
arising from PCAT). Brieﬂy, a section was reacted with anti-oxLDL
antibody (Anti-oxLDL-antibody orb 10973; rabbit polyclonal, which
reacts with human oxLDL [21]; Biorbyt Ltd, Cambridge, UK) diluted
100-fold (mg/mL) for 60 min, the peroxidase reaction was devel-
oped by 3,30-diaminobenzidine tetrahydrochloride using Envision
kit (Code No. K4061, DAKO Co., Glostrup, Denmark) for 30 min, and
ﬁnally the cell nuclei were stained with hematoxylin. The following
sections were pretreated similarly, and reacted with Anti-LDL
antibody ab 157795, chicken polyclonal to LDL, reacts with human
LDL. Immunogen LDL puriﬁed from human plasma (Abcam Ltd),
Anti-HDL antibody [1C5] ab 34788 abcam. Mouse monoclonal[1C5]
to HDL, the antibody reacts with HDL2 and HDL3, reacts with human
HDL (Abcam Ltd, Tokyo, Japan), anti-CD68 antibody mouse
monoclonal NCL-CD 68-KP1; antigen lysosomal granules from
human lung macrophages (Leica Biosystems Newcastle Ltd, New-
castle, UK) to stain macrophages [22,23], and anti-CD31-antibody,
rabbit polyclonal; immunogen: synthetic peptide corresponding to
C terminals of mouse CD31; reacts with mouse and human CD31
(Abcam Ltd, Tokyo), to stain CD31 in the endothelial cells of vasa
vasorum. Using these immunohistochemical techniques, all rele-
vant molecules were stained brown.
Double immunohistochemical staining. Double staining of oxLDL
and CD68 was performed to conﬁrm that oxLDL-containing
mononuclear cells were macrophages. Brieﬂy, after washing with
phosphate-buffered saline, a section was reacted with anti-CD68
antibody as described for 60 min, and with anti-mouse Alexa555
(Alexa Fluoro555 goat anti-mouse IgG, Code No. A21422, Molecu-
lar Probes Ltd, CA, USA) for 30 min to elicit the red ﬂuorescence of
CD68. The same section was then reacted with anti-oxLDL
antibody for 60 min, and with anti-rabbit FITC (FITC conjugated
AffeiniPureoat Anti-Rabbit IgG, Code No. 111-095-003, Vector
Laboratories Inc, Burlingame, CA, USA) for 30 min to elicit the green
ﬂuorescence of oxLDL. Finally, the section was reacted with DAPI
(40,6-diamidino-2-phenylindole; Life Technologies Carlsbad, Carls-
bad, CA, USA) to elicit the blue ﬂuorescence of cell nuclei [24]. Also,
oxLDL with HDL, and CD31 with oxLDL, LDL or HDL was stained.
Stained sections were photographed separately or merged
together under a confocal laser scanning microscope (FLUOVIEW
FV 1700; Olympus Co, Tokyo, Japan) using a 460-nm band-pass
ﬁlter and a 510-nm band absorption ﬁlter to obtain the green
ﬂuorescence, 555-nm and a 575-nm ﬁlters to obtain the red
ﬂuorescence of other substance, and a 345 nm BPF and 420 nm BAF
to obtain the blue ﬂuorescence.
Microscopic observation of PCAT and coronary artery after
immunohistochemical staining
Deﬁnition of the deposition patterns. Histological observation of the
deposition of oxLDL, LDL and HDL was performed using amicroscope (IX 70, Olympus Co., Tokyo, Japan), and it was
classiﬁed as dotted (i.e. pencil-tip-like small points with diameter
30 mm) or diffuse (diameter >30 mm). We considered the dotted
deposition was signiﬁcant if the dot density was 5/
200  200 mm2, because a small number of dots were disseminat-
ed not only in the intima but also in the PCAT in the majority of
sections stained for oxLDL.
Relationship between plaque morphology and depositions of oxLDL,
LDL and HDL. Percentage (%) deposition of the target substances
(both dotted and diffuse patterns) in PCAT, adventitia, and intima
was compared among normal coronary segments, white plaques
and yellow plaques with and without necrotic core (NC).
Deposition in the intima (including plaque) was further classiﬁed
as inner half (luminal side) or outer half (medial side).
Relationship between oxLDL-containing macrophages in the intima
and PCAT. Using double-immunohistochemically stained prepara-
tions, the relationship between the density of these macrophages
in the intima and PCAT was examined to understand the origin of
oxLDL-containing macrophages in the intima. Because LDL and
HDL were not contained in macrophages, this procedure was not
carried out for them.
Relationship between intimal vasa vasorum and oxLDL, LDL, and HDL
deposition. By staining with CD31, a marker of vascular endothelial
cells, we examined whether the deposition of these lipoproteins in
the intima depends on the formation of intimal vasa vasorum,
which penetrates the adventitia and media (penetrating micro-
vessels) into the intima.
Statistical analysis
The data obtained were tested by Fisher’s exact test. A value of
p < 0.05 was considered to be statistically signiﬁcant.
Results
Storage of OxLDL, LDL and HDL in Human PCAT
OxLDL and HDL were stained in all PCAT specimens (i.e.,
epicardial adipose tissue located within 3 mm of an epicardial
coronary artery), irrespective of the presence or absence of
atherosclerotic plaques in the adjacent coronary segments, sex
and underlying disease, whereas LDL was rarely stained (A-1–D-1
in Fig. 2a, Table 1A). OxLDL and HDL were found not only in the
cytoplasm but also in the plasma membrane of adipocytes that
comprise PCAT (A-2–C-2 in Fig. 2a), indicating a storage function.
Double staining revealed that oxLDL and HDL co-deposited in the
same adipocytes of PCAT (Fig. 2b).
Deposition of OxLDL, LDL and HDL in the coronary wall
OxLDL was deposited in diffuse pattern in PCAT, in a dotted
pattern only in the adventitia and media, and in either a dotted (A-
1 in Fig. 2a, A, A-3 in Fig. 3) or diffuse pattern (B-1 in Fig. 2a) in the
coronary intima. HDL deposited in a diffuse pattern only in PCAT
and intima (C-1 in Fig. 2a). LDL deposited in a diffuse pattern in
PCAT and intima infrequently (D-1 in Fig. 2a; Tables 1A and 1B).
Relationships between deposition of OxLDL, LDL and HDL and plaque
morphology on angioscopy
The percentage (%) incidence of oxLDL, in PCAT and adventitia
was 100, irrespective of the presence or absence of coronary
atherosclerotic plaques and their morphology (Table 1A). The %
Fig. 2. Localization and deposition patterns of oxidized low-density lipoprotein
(OxLDL) in human pericoronary adipose tissues (PCAT) and the coronary arterial
wall. (a) (A) Yellow plaque by angioscopy. Immunohistochemical staining shows,
the plaque (arrow in A) contains dotted oxLDL deposits (arrow in A-1) and diffuse or
dotted oxLDL deposits in the PCAT (arrowhead in A-1). Under magniﬁcation, oxLDL
is deposited not only in the cytoplasm (arrow in A-2) but also in the plasma
membrane of adipocytes (AC; arrowhead in A-2). (B). White plaque by angioscopy.
Immunohistochemical staining shows, diffuse oxLDL deposits in the intima (arrow
in B-1) and PCAT (arrowhead in B-1). Under magniﬁcation, oxLDL is deposited in the
cytoplasm (arrow) and plasma membrane (arrowhead in B-2). (C) Yellow plaque by
angioscopy (arrow). Immunohistochemical staining shows, diffuse HDL deposits in
the intima (arrow in C-1) and PCAT (arrowhead in C-1). Under magniﬁcation, HDL
deposited in both the cytoplasm (arrow in C-2) and plasma membrane (arrowhead
in C-2). The cytoplasm is partially lost during preparation of the slide. (D) White
plaque by angioscopy (arrow). Immunohistochemical staining shows, LDL
deposited in the intima (arrow in D-1) but not in PCAT (arrowhead in D-1).
Under magniﬁcation, LDL was not observed in the cytoplasm or plasma membrane
(arrowhead in D-2). AC: adipocyte, I: intima, M: media, and Ad: adventitia. Scale
bars in A-1–D-2 = 100 mm. Scale bars in A-2–D-2 = 5 mm. (b). Double
immunohistochemical staining of OxLDL (green by FITC-labeling) and HDL (red
by Alexa 555-labeling). Adipocytes of the PCAT are ﬁlled with oxLDL and HDL
(arrows in A–A-2). Under magniﬁcation, oxLDL and HDL co-localized in the
cytoplasm (arrows in B–B-2) and plasma membrane of the same adipocytes
(arrowheads in B–B-2). Scale bars in A–A-2 and B–B-2 = 20 mm and 5 mm,
respectively. HDL: high-density lipoprotein. OxLDL: oxidized low-density
lipoprotein. PCAT: pericoronary adipose tissue.
Table 1A
Incidence of OxLDL, LDL and HDL in pericoronary adipose tissue (PCAT) and relation
to plaque morphology in the adjacent coronary artery.
n Incidence in PCAT
OxLDL (%) LDL (%) HDL (%)
Normal segments 29 29 (100)** 1 (4) 29 (100)**
White plaques 19 19 (100)yy 2 (10) 19 (100)yy
Yellow plaques NC() 15 15 (100)z 0 (0) 15 (100)z
Yellow plaques NC(+) 14 14 (100)§ 1 (7) 14 (100)§
n = number of specimens examined.
** p < 0.01 vs. LDL in normal segments.
yy p < 0.01 vs. LDL in white plaques.
z p < 0.05 vs. LDL in yellow plaques (NC).
§ p < 0.05 vs. LDL in yellow plaques (NC+).
Fig. 3. Comparison of dotted OxLDL deposits and CD68(+)-macrophages. Adjacent
sections were stained immunohistochemically for oxLDL or CD68(+)-macrophages
for comparison. Both the oxLDL deposits and CD68(+)-macrophages showed round
(arrowhead in A, A-1) or spindle-like conﬁguration (arrows in A, A-1; B, B-1; C, C-1; D,
D-1). Dotted deposits of oxLDL and CD68(+)-macrophages (arrows in B, B-1, C, C-1)
traversing the external elastic lamina (EEL; white arrowheads in B, B-1) and internal
elastic lamia (IEL; white arrowheads in C, C-1) were demonstrated. Vacuole-like
structures surrounded by oxLDL or CD68 were also observed in the intima
(arrowheads in D, D-1), suggesting foam cells. Scale bars = 20 mm. I, M and Ad:
intima, media and intima, respectively. OxLDL: oxidized low-density lipoprotein.
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increased in white (early stage) and yellow plaques without
necrotic core (NC; mature stage) and reduced in yellow plaques
with NC (end-stage of maturation) that were classiﬁed byconventional angioscopy and histology (Table 1B). The incidence
of LDL depositions was low and showed no signiﬁcant relation to
plaque morphology (Table 1B). The incidence of HDL was low in
normal segments, increased with plaque growth, and further with
plaque maturation (Table 1B).
Co-deposition of OxLDL, LDL and HDL in the same portion of coronary
intima
It is a general belief that LDL enters the intima from its lumen
and becomes oxLDL. If so, it is natural to consider that they would
closely or co-deposit in the same portion. LDL rarely co-deposited
with oxLDL, whereas HDL frequently co-deposited with oxLDL
(Table 1C).
Distribution of dotted deposits of OxLDL and CD68(+)-macrophages
Under magniﬁcation, dotted deposits were revealed to be
mononuclear cells containing oxLDL, in either a round or spindle-
like conﬁguration in the PCAT, adventitia and intima. Because this
conﬁguration resembled that of macrophages, the localization of
Table 1B
Incidence of OxLDL, LDL and HDL in normal coronary segments and plaques.
n Incidence in coronary intima
OxLDL (%) LDL (%) HDL (%)
Normal segments 29 6 (21) 3 (10) 10 (34)
White plaques 19 15 (75)*,y 3 (16) 14 (73)*
Yellow plaques NC() 15 8 (53) 6 (40) 14 (93)
Yellow plaques NC(+) 14 5 (36) 3 (21) 14 (100)z,§
* p < 0.05 vs. LDL in white plaques.
y p < 0.05 vs. oxLDL in normal segments.
z p < 0.05 vs. LDL in yellow plaques (NC+).
§ p < 0.05 vs. HDL in normal segments.
Table 1C
Co-localization of OxLDL, LDL and HDL in coronary intima.
Normal
segments
White
plaques
Yellow
plaques
(NC)
Yellow
plaques
*(NC+)
n 29 19 15 14
(a) Solitary deposition
OxLDL (%) 2 (7) 3 (15) 0 (0) 0 (0)
LDL (%) 1 (3) 0 (0) 0 (0) 0 (0)
HDL (%) 5 (17) 4 (23) 2 (13) 4 (28)
(b) Co-deposition
OxLDL + LDL (%) 0 (0) 2 (16) 0 (0) 0 (0)
OXLDL + HDL (%) 3 (10) 5 (26)* 5 (36)y 3 (23)
LDL + HDL (%) 2 (8) 0 (0) 2 (14) 3 (22)
OxLDL + LDL + HDL (%) 2 (8) 5 (26)zz 3 (21)§ 4 (28)LL
* p < 0.05 vs. LDL + HDL in white plaques.
y p < 0.05 vs. oxLDL + LDL in yellow plaques without NC.
zz p < 0.01 vs. oxLDL + LDL + HDL in normal segments.
§ p < 0.05 vs. oxDL + LDL + HDL in normal segments.
LL
p < 0.01 vs. OxLDL + LDL + HDL in normal segments.
Fig. 4. OxLDL-containing CD68(+)-macrophages demonstrated by double
immunohistochemical staining. (a). Because the conﬁguration of dotted oxLDL
deposits resembled that of macrophages, double immunohistochemical staining of
oxLDL (green by FITC-labeling) andCD68(+)-macrophages (red by Alexa 555-labeling)
was performed. It showed that oxLDL was not contained in CD68(+)-macrophages
which localized inside the adventitial vasa vasorum (arrows in A–A-2), but was
contained in those in PCAT (B–B-2). Scale bars = 5 mm. Arrowheads: nucleus. (b).
OxLDL-containing CD68(+)-macrophages were observed in the adventitial connective
tissues outside the vasa vasorum (arrows in A–A-2), and media (arrows in B–B-2).
Scale bars = 5 mm. (c), OxLDL-containing CD68(+)-macrophages in intima (arrows in
A–A-2). Scale bars = 5 mm. Arrowheads: foam cells.
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phages), was compared in adjacent sections. OxLDL deposits in a
spindle-like or round conﬁguration and CD68(+)-macrophages
with similar conﬁgurations were observed in the connective
tissues of the PCAT, adventitia, media and intima (Fig. 3). In
addition, those with the spindle-like conﬁguration were observed
traversing both the external elastic lamina (B, B-1 in Fig. 3), and
internal elastic lamia (C, C-1 in Fig. 3). Vacuole-like structures
circumscribed by oxLDL or CD68 deposits were also observed in
the intima, suggesting foam cells, which are well known to be
formed from macrophages (D, D-1 in Fig. 3).
Absence of OxLDL-containing CD68(+)-macrophages inside the vasa
vasorum
Using double immunohistochemical staining of oxLDL and
CD68, macrophages inside the adventitial and intimal vasa
vasorum were shown not to contain oxLDL (A–A-2 in Fig. 4a).
Transfer of OxLDL by CD68(+)-macrophages
Using double immunohistochemical staining, oxLDL-contain-
ing CD68(+)-macrophages with a spindle-like conﬁguration were
observed not only in the interstitial space of PCAT (arrows in B–B-2
in Fig. 4a) but also in the adventitia (arrows in A–A-2 in Fig. 4b),
media (arrows in B–B-2 in Fig. 4b) and intima (arrows in A–A-2 in
Fig. 4c). In addition, vacuole-like structures in the intima were
shown to be foam cells because they were positive to oxLDL and
CD68 staining (arrowheads in A–A-2 in Fig. 4c).Relationships of the density of OxLDL-containing macrophages in the
intima and PCAT
In order to examine whether there is any relationship between
oxLDL-containing CD68(+)-macrophages in the intima and those in
Table 1D
Deposition patterns of OxLDL, LDL and HDL and their relation to the presence or
absence of intimal vasa vasorum.
n Vasa vasorum
Absent Present
(1) OxLDL
Dotted pattern (%) 22 17 (77)* 5 (23)
Diffuse pattern (%) 12 1 (8) 11 (92)y,z
(2) HDL
Dotted pattern (%) 52 0 (0) 0 (0)
Diffuse pattern (%) 52 4 (7) 48 (92)§§§
(3) LDL
Dotted pattern (%) 15 0 (0) 0 (0)
Diffuse pattern (%) 15 5 (33) 10 (66)
* p < 0.05 vs. dotted pattern of oxLDL in vasa vasorum present group.
y p < 0.05 vs. diffuse pattern in vasa vasorum absent group.
z p < 0.05 vs. dotted pattern in vasa variorum present group.
§§§ p < 0.001 vs. HDL in vasa vasorum absent group.
Table 1E
Localization of diffuse OxLDL, LDL and HDL deposits, and its relation to intimal vasa
vasorum.
Localization of vasa vasorum in coronary intima
Inner half Outer half Both halves
(1) OxLDL
n 2 2 5
Inner half (%) 2 (100) 1 (20) 1 (20)
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The density (number/200  200 mm2) of oxLDL-containing macro-
phages in the intima and PCAT showed a linear relationship [i.e., Y
(density in intima) = 0.82  (density in PCAT) + 3.52, r = 0.792,
p < 0.0001], indicating that oxLDL-containing CD68(+)-macro-
phages accumulated in both portions in parallel.
Co-localization of diffuse OxLDL and HDL deposits with intimal vasa
vasorum
Co-localization of oxLDL, LDL and HDL with intimal vasa
vasorum (stained by anti-CD31 antibody) was compared using
adjacent sections. In the presence of intimal vasa variorum, oxLDL
deposits showed a diffuse pattern (A, B in Fig. 5a, Table 1D), but
showed dotted pattern in the absence of vasa vasorum (Table 1D).
HDL co-localized with vasa vasorum (A-1, A-3; B-1, B-3 in
Fig. 5a). Double immunohistchemical staining of HDL and vasa
vasorum also showed their co-deposition (Fig. 5b). Co-deposition
of diffuse HDL deposits and vasa vasorum was more frequently
observed in the outer half (medial side) in white plaques than
normal segments and yellow plaques, and in both the inner
(luminal side) and outer halves of the intima more frequently in
yellow plaques, indicating that HDL spread with the development
of vasa vasorum (Table 1E).
Diffuse oxLDL deposits and vasa vasorum showed similar
relationships (Table 1E). There was no signiﬁcant relationship
between LDL deposits and intimal vasa vasorum (Table 1E).Fig. 5. Co-localization of OxLDL and HDL with vasa vasorum. (a). Four adjacent
sections were stained in the order of oxLDL, LDL, HDL and vasa vasorum (CD31).
When vasa vasorum was localized to the outer half of the intima, i.e., medial side (A-
3), oxLDL and HDL deposited in the same portion (A, A-1) but LDL not (A-2). When
vasa vasorum was distributed to both inner and outer halves of the intima (B-3),
both oxLDL and HDL deposited in both halves of the intima (B, B-1). Scale
bars = 100 m m. (b). Double immunohistochemical staining of HDL and vasa
vasorum (CD31) showed their co-localization (arrows in A–A-2). Scale
bars = 20 mm.
Outer half (%) 0 (0) 3 (60) 1 (20)
Both halves (%) 0 (0) 1 (20) 3 (41)
(2) HDL
n 3 20 29
Inner half (%) 1 (33) 2 (10) 1 (3)
Outer half (%) 0 (0) 15 (75)*,y,zz 2 (7)
Both halves (%) 2 (66) 3 (15)
LL
26 (89)§§§
(3) LDL
n 2 6 7
Inner half (%) 1 (50) 1 (16) 1 (14)
Outer half (%) 0 (0) 4 (66) 2 (28)
Both halves (%) 1 (50) 1 (16) 4 (57)
HDL, high-density lipoprotein; OxLDL, oxidized low-density lipoprotein;
NC(): necrotic core absent. NC(+): necrotic core present.
* p < 0.05 vs. HDL in inner half of intima in the group in which vasa vasorum
located in outer half.
y p < 0.05 vs. HDL in both halves of intima in the group in which vasa vasorum
located in outer half.
zz p < 0.01 vs. HDL in the group in which vasa vasorum located in both halves.
§§§ p < 0.001 vs. HDL in outer half or inner half of intima in the group in which
vasa vasorum located in both halves.
LL
p < 0.01 vs. HDL in the group in which vasa vasorum located in both halves.Discussion
Storage of OxLDL and HDL in PCAT
Using immunohistochemical techniques, we found that oxLDL
and HDL co-deposited in all human PCAT specimens, irrespective
of the presence or absence of atherosclerotic plaques in the
adjacent coronary arterial wall, or patient’s age, sex and underlying
disease at least in the cases examined in the present study,
indicating that human PCAT is a common storage site of these
lipoproteins.
Storage of oxLDL and HDL was observed in the PCAT of normal
coronary segments, indicating that it begins to store these
lipoproteins before atherosclerosis develops. Storage of LDL in
the PCAT was infrequent; this ﬁnding suggests that oxLDL was not
formed from LDL within the PCAT but was supplied to the PCAT
from elsewhere (i.e., via penetrating microvessels that connect the
myocardium to PCAT), or via penetrating microvessels that
Fig. 6. Possible mechanisms of the storage and supply of OxLDL and HDL to coronary
intima. Schematic representation of a hitherto unrecognized supply route of oxLDL
and HDL to the coronary intima. OxLDL and HDL are stored in PCAT. The former is
conveyed by either CD68(+)-macrophages or neovascularized vasa vasorum and the
latter by vasa variorum to the intima. EC: endothelial cells. MMPs: matrix
metalloproteases. MPO: myeloperoxidase. HOCl: hypochlorous acid.
Y. Uchida et al. / Journal of Cardiology 69 (2017) 236–244242connect to adventitial vasa vasorum arising from the systemic
circulation.
Evidences supporting supply of OxLDL from the PCAT to coronary
intima by CD68(+)-macrophages
The deposition pattern of oxLDL in intima was either dotted or
diffuse. It was revealed that CD68(+)-macrophages containing
oxLDL showed a dotted deposition pattern and were distributed
not only in the PCAT but also in adventitia, media and intima.
OxLDL-containing CD68(+)-macrophages traversing the external
and internal elastic laminae were frequently observed, and their
density in the intima positively correlated with that in the PCAT.
In addition, the CD68(+)-macrophages outside the vasa vasorum
contained oxLDL but those inside did not. Although real-time
movements of the CD68(+)-macrophages from PCAT toward the
intima could not be observed because excised coronary speci-
mens were used, the ﬁndings strongly suggest that the CD68(+)-
macrophages not containing migrated from outside (via adventi-
tial vasa vasorum from systemic circulation or penetrating
vessels from the myocardium) into the PCAT, received oxLDL
within the PCAT and migrated through the interstitial space into
the intima.
Macrophage phenotypes
CD68 is a marker of macrophages/monocytes. There are many
phenotypes which inﬂuence atherosclerosis or angiogenesis, i.e.,
M2d, M4, Mox, HA-mac, M(Hb), Mhem, etc. [22]. It remains to be
elucidated which phenotype (s) conveys oxLDL to the intima.
PCAT as possible supply site of diffuse OxLDL and HDL deposits in
intima
In the present study, PCAT contained HDL in all specimens
examined, irrespective of age, sex and underlying diseases. There
are at least two possible supply sites of HDL, i.e., the HDL in the
systemic circulation was supplied to the intima through the vasa
vasorum while to the PCAT through the penetrating vessels from
the myocardium or adventitial vasa vasorum, or the HDL stored in
the PCAT was supplied to the intima through the penetrating
vessels (so-called neovascularized vasa vasorum). The movements
of HDL could not be examined because an immunohistochemcal
technique was employed in the present study.
It is well known that PCAT supplies a number of cytokines to the
vessel wall and it is considered that the penetrating vessels convey
them to the vessel wall [1]. It is therefore likely that HDL was
supplied from the PCAT to coronary plaques in the present study.
Signiﬁcance of vasa vasorum in supplying OxLDL and HDL to coronary
intima
Diffuse oxLDL and HDL deposits were observed in the intima
where vasa vasorum was demonstrated, indicating that, in
addition to CD68(+)-macrophages, oxLDL was also conveyed from
the PCAT to intima by vasa vasorum, and HDL solely by vasa
vasorum. There were a small number of preparations in which
diffuse oxLDL or HDL was deposited but vasa vasorum was not
demonstrated. As neovascularized vasa vasorum has very small
diameter, there is a possibility that it was not visualized by
immunohistochemical staining.
HDL co-localized with vasa vasorum in the outer half (media
side) of the intima in white plaques (early stage of plaque growth),
and in both the inner and outer halves of the intima in yellow
plaques (mature stage), suggesting that initially vasa vasorum
grew from the adventitial side into the outer half of the intima andsupplied HDL to this region, and in the mature stage of plaques,
vasa vasorum extended further to the inner half and supplied HDL
to both halves. Similar tendency was observed in the case of
diffuse oxLDL deposits, suggesting oxLDL was supplied by the
same route.
Supply route of LDL to intima
Because LDL was rarely stored in PCAT, it is likely that LDL
deposited in the intima was supplied from the sites other than
PCAT (i.e., from the lumen).
Relationships between plaque morphology on angioscopy and intimal
deposition of OxLDL, LDL and HDL
Percent incidence of oxLDL was low in normal segments,
increased with plaque growth (white plaques) and decreased in
the mature stage of plaques (yellow plaques with NC). It is
conceivable that oxLDL is catabolized or replaced by other
molecules.
In contrast, HDL increased with plaque growth and further with
plaque maturation. HDL is a good acceptor of cholesterol derived
from foam cells. HDL also transfers cholesteryl esters to triglycer-
ide-rich particles via cholesteryl ester transfer protein [25]. The
increased HDL in mature plaques may have acted to regress the
plaque through these mechanisms.
General belief of the mechanisms of atherosclerosis
It is generally believed that mononuclear cells enter the
vascular wall from the lumen and become macrophages; LDL also
enters the vascular wall from the lumen and becomes oxLDL, and
macrophages accumulate oxLDL and ﬁnally become foam cells,
while releasing metalloproteases, collagenases or myeloperox-
idase and its product hypochlorous acid, to accelerate atheroscle-
rosis [26–28]. Also, it is a general belief that HDL, a counterpart of
oxLDL, enters the vascular wall directly from its lumen or indirectly
through vasa vasorum. The results from the present study
suggested the existence of hitherto unrecognized supply routes
of oxLDL and HDL to the vascular intima (Fig. 6).
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(1) Because the majority of patients were admitted in serious
condition at terminal stage, it was impossible to examine
epicardial fat or BMI. In addition, except for the patients with
AMI and OMI, history taking was incomplete and plasma lipid
levels examined at the terminal stage were considered not
reﬂect their levels at stable condition. Heart weight/body
lengths or weight was not measured.
(2) Although storage of both oxLDL and HDL in human PCAT was
proven, the following mechanisms remain to be elucidated.
(a) Although the ﬁndings of the present study strongly
suggested that oxLDL is conveyed by macrophages or vasa
vasorum and HDL by vasa vasorum, real-time movement of
these lipoproteins was not examined, and should be
clariﬁed by tracing labeled native oxLDL or HDL in patients
in vivo. Also, what subtype of macrophages convey oxLDL
remains to be elucidated.
(b) It remains to be elucidated what kind(s) of factor(s)
regulate storage of oxLDL or HDL in the PCAT and supply
to the intima.
(c) It remains to be elucidated whether oxLDL and HDL are
synthetized in the PCAT, or from where and how they were
conveyed to the PCAT.
Conclusions
Using immunohistochemical techniques, we found that oxLDL
and HDL were stored in human PCAT, and it was suggested that
oxLDL was supplied to the coronary intima, which is the site of
atherosclerosis, either by CD68(+)-macrophages or vasa vasorum
and HDL by vasa vasorum only. OxLDL begins to deposit in the
coronary intima before plaque formation, increasingly deposits
with plaque growth and decreases with plaque maturation,
whereas HDL begins to deposit with plaque formation, increasingly
deposit with plaque growth and further deposits with plaque
maturation.
One possible reason for weak effects of conventional lipid-
lowering therapy in plaque regression and reduction of coronary
events [29,30] is the ignorance of the role of PCAT in
atherosclerosis.
Therefore, molecular therapy targeting PCAT to inhibit
oxLDL storage or its supply to the intima and to accelerate
storage and supply of HDL to the intima before plaque growth
could be an effective preventive treatment for human coronary
atherosclerosis.
Clinical competencies
Based on the general belief that LDL enters the vascular
wall from the lumen and becomes oxLDL to cause atherosclerosis,
therapies to lower plasma LDL have been attempted intensively
in anticipation for prevention or regression of atherosclerosis, but
with insufﬁcient plaque regression and reduction in coronary
events. One possible reason for such clinical ineffectiveness of
lipid-lowering therapy is ignorance of the supply route of oxLDL
and HDL from the PCAT to the vascular intima.
Translational outlook
Molecular therapy targeting the PCAT to inhibit oxLDL storage
and its supply to the coronary intima and to accelerate HDL storage
and its supply to the intima could be effective in preventing
coronary atherosclerosis.Disclosure
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